AC
PFE icon

Annandale Capital’s Pfizer PFE Stock Holding History

Annandale Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,571
Closed -$520K – 134
2024
Q2 		$520K Buy
18,571
+3
+0% +$83 0.09% 89
2024
Q1 		$515K Buy
18,568
+9,925
+115% +$275K 0.09% 92
2023
Q4 		$249K Buy
8,643
+2,087
+32% +$63.1K 0.05% 115
2023
Q3 		$217K Sell
6,556
-1,449
-18% -$51.2K 0.05% 110
2023
Q2 		$294K Buy
8,005
+1,885
+31% +$73.4K 0.09% 105
2023
Q1 		$250K Sell
6,120
-102
-2% -$4.41K 0.08% 108
2022
Q4 		$319K Sell
6,222
-187
-3% -$8.96K 0.1% 101
2022
Q3 		$280K Buy
6,409
+2
+0% +$97 0.1% 104
2022
Q2 		$336K Buy
6,407
+965
+18% +$49.2K 0.13% 97
2022
Q1 		$282K Sell
5,442
-4,725
-46% -$245K 0.11% 92
2021
Q4 		$600K Sell
10,167
-1,326
-12% -$65.7K 0.26% 67
2021
Q3 		$494K Sell
11,493
-302
-3% -$13.4K 0.3% 57
2021
Q2 		$462K Buy
11,795
+1,102
+10% +$42.9K 0.28% 60
2021
Q1 		$387K Sell
10,693
-283
-3% -$10K 0.27% 48
2020
Q4 		$404K Buy
+10,976
New +$403K 0.34% 36

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Annandale Capital's PFE Position: Q3 2024 in Review

Annandale Capital sold out of Pfizer (PFE) in Q3 2024, closing a stake of 18,571 shares — an estimated $520K sold.

Annandale Capital first reported a position in PFE in Q4 2020 and held it in 15 quarters. The position peaked at $600K in Q4 2021. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Annandale Capital reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Annandale Capital sold 18,571 Pfizer shares in Q3 2024, an estimated $520K.
  • Annandale Capital first reported a position in Pfizer in Q4 2020 and held it in 15 quarters.
  • Annandale Capital's Pfizer position peaked at $600K in Q4 2021.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Annandale Capital's 13F filing for Q3 2024, filed 12 Nov 2024.